Skip to main navigation
Skip to search
Skip to main content
Aston Research Explorer Home
Help & FAQ
Link opens in a new tab
Search content at Aston Research Explorer
Home
Research units
Profiles
Research Outputs
Datasets
Student theses
Activities
Press/Media
Prizes
Equipment
Aspirin and aspirin analogs on esophageal cancer
Rajagopal Sharada Kilari
, Christopher J. Perry
,
Andrew Devitt
, Stephen T. Safrany
, Iain D. Nicholl
College of Health and Life Sciences
Aston Research Centre for Health in Ageing
Cell & Tissue Biomedical Research
University of Wolverhampton
Research output
:
Contribution to journal
›
Conference abstract
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Aspirin and aspirin analogs on esophageal cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Esophageal Cancer
100%
Aspirin
100%
Aspirin Analogues
100%
Cyclooxygenase Enzyme
37%
Esophageal Cancer Cell Line
37%
Apoptosis
25%
Esophageal Adenocarcinoma
25%
Adenocarcinoma Cells
25%
Cyclooxygenase-1 (COX-1)
12%
Cause of Death
12%
Necrosis
12%
Apoptosis Induction
12%
Epidemiological Study
12%
Daily Intake
12%
MTT Assay
12%
Colorimetric Assay
12%
Metabolic Activity
12%
Cyclooxygenase Inhibitors
12%
Anticancer Drugs
12%
Peroxidase
12%
Most Common Cause
12%
Common Cancers
12%
OE33
12%
Tumor Cell Death
12%
Antiproliferative Properties
12%
Squamous Carcinoma Cells
12%
Esophageal Cancer Cells
12%
Flow Cytometry Analysis
12%
Antiproliferative Effect
12%
Pharmacology, Toxicology and Pharmaceutical Science
Acetylsalicylic Acid
100%
Esophagus Cancer
100%
Prostaglandin Synthase
31%
Enzymes
18%
Malignant Neoplasm
12%
Esophageal Adenocarcinoma
12%
Side Effect
12%
Neoplasm
6%
Necrosis
6%
Anticarcinogen
6%
Peroxidase
6%
Lactoperoxidase
6%
Squamous Cell Carcinoma
6%
Low Drug Dose
6%
Immunology and Microbiology
Esophageal Cancer Cell Line
60%
Squamous Cell Carcinoma Cell
20%